ResearcherUniversity of PittsburghNo recent work listed
Anil K. Dasyam
Matched on ORCID iD 0000-0003-1322-8680; OpenAlex author ID A5028104786. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 45
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 2 papers
Papers 6
- Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict … Co-author DOI 10.1016/j.cgh.2020.11.041↗
- Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consor… Co-author DOI 10.2214/ajr.22.27859↗
- Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Co-author DOI 10.1148/rycan.2020190020↗
- Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Ea… Co-author DOI 10.3389/fonc.2020.596931↗
- Reporting Standards for Chronic Pancreatitis by Using CT, MRI, and MR Cholangiopancreatography: The Consortium for the Study of Chronic Pancreatitis, Diabetes,… Last author DOI 10.1148/radiol.2018181353↗
- Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.6004/jnccn.2017.0058↗
Closest collaborators
The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aatur Dilip Singhi · 3 shared papers, 2017–2022 · strength 0.24
- Paper Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated P… DOI 10.1016/j.cgh.2020.11.041↗
- Paper Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pr… DOI 10.3389/fonc.2020.596931↗
- Paper Identification of Targetable ALK Rearrangements in Pancreatic Ductal Adenocarcinoma. DOI 10.6004/jnccn.2017.0058↗
- Randall E. Brand · 2 shared papers, 2020–2022 · strength 0.19
- Paper Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated P… DOI 10.1016/j.cgh.2020.11.041↗
- Paper Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pr… DOI 10.3389/fonc.2020.596931↗
- Walter Gwang-Up Park · 2 shared papers, 2019–2020 · strength 0.17
- Paper Reporting Standards for Chronic Pancreatitis by Using CT, MRI, and MR Cholangiopancreatography: The Consortium for the … DOI 10.1148/radiol.2018181353↗
- Paper Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pr… DOI 10.3389/fonc.2020.596931↗
- Herbert J. Zeh · 2 shared papers, 2017–2022 · strength 0.16
- Nathan Bahary · 2 shared papers, 2017–2022 · strength 0.16
- Jessica N. Everett · 1 shared paper, 2022 · strength 0.13
- Alexander Savio Ramos Guimaraes · 1 shared paper, 2022 · strength 0.13
- Joy Liau · 1 shared paper, 2022 · strength 0.13
- Lyndon Luk · 1 shared paper, 2022 · strength 0.13
- Chenchan Huang · 1 shared paper, 2022 · strength 0.13
- Diane M. Simeone · 1 shared paper, 2022 · strength 0.13
- Elizabeth M. Hecht · 1 shared paper, 2022 · strength 0.13
- Avinash R. Kambadakone · 1 shared paper, 2022 · strength 0.13
- Alec J. Megibow · 1 shared paper, 2022 · strength 0.13
- Ajaykumar C. Morani · 1 shared paper, 2020 · strength 0.13
- Srinivasa R. Prasad · 1 shared paper, 2020 · strength 0.13
- Rohit Kumar Das · 1 shared paper, 2022 · strength 0.10
- Melissa Ellen Hogg · 1 shared paper, 2022 · strength 0.10
- Susannah G. Ellsworth · 1 shared paper, 2022 · strength 0.10
- Asif Khalid · 1 shared paper, 2022 · strength 0.10
- Amer H. Zureikat · 1 shared paper, 2022 · strength 0.10
- Brian A. Boone · 1 shared paper, 2022 · strength 0.10
- Alessandro Paniccia · 1 shared paper, 2022 · strength 0.10
- Temel Tirkes · 1 shared paper, 2019 · strength 0.09
- Mark D. Topazian · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.